Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


Nerve block eases troublesome hot flashes

Randomized, controlled trial shows anesthetic could be alternative to hormones and other medications

Injecting a little anesthetic near a nerve bundle in the neck cut troublesome hot flashes significantly, shows a new randomized, controlled trial published online today in Menopause, the journal of The North American Menopause Society (NAMS). The technique could give women who cannot or prefer not to take hormones or other medications an effective treatment alternative.

In this study from two Chicago medical schools, Northwestern University and the University of Illinois at Chicago, 40 women who had moderate to severe hot flashes got either a stellate ganglion block—an injection of tiny amounts of anesthetic near a nerve bundle in the neck—or an injection of plain saline solution.

Both groups of women kept diaries of the frequency and severity of their hot flashes from two weeks before the injection until six months afterward. In addition, for 24 hours at the start of the study and three months after the injection, the women wore skin conductance monitors, which measured hot flashes objectively and also let the women record when they felt a hot flash.

On average, the women had 10 hot flashes a day, rating two-thirds of them moderate or severe. (Hot flashes lasting up to 15 minutes with symptoms such as perspiration, clammy skin, dry mouth, tense muscles, and rapid heartbeat were considered "moderate." Hot flashes lasting up to 20 minutes with symptoms such as "raging furnace" warmth, weakness, feeling faint, extreme perspiration, and heart irregularities were considered "severe.")

Four to six months after the injection, the total number of hot flashes wasn't significantly different between the real- and sham-treated groups, but the number of moderate to severe hot flashes was cut in half for women who got the real nerve block (52%) compared with just 4% for the women who got the sham injection. What's more, the intensity of the hot flashes dropped 38% for the women who got the real nerve block, compared with just 8% for those who got the sham injection.

"A few small studies suggested that this treatment had potential, but this is the first study to show that this hot flash treatment really is better than placebo. The nerve blocks could prove very helpful for women with a history of breast cancer, as well as for women who prefer not to use hormones or other drugs for hot flashes," says NAMS Executive Director Margery Gass, MD.

The study, "Effects of stellate ganglion block on vasomotor symptoms: findings from a randomized controlled clinical trial in postmenopausal women," was supported by the Department of Obstetrics and Gynecology, Northwestern University and grants from the National Institute of Child Health and Human Development and the National Institutes of Health Office of Research on Women's Health and will be published in the August 2014 print edition of Menopause.

Founded in 1989, The North American Menopause Society (NAMS) is North America's leading nonprofit organization dedicated to promoting the health and quality of life of all women during midlife and beyond through an understanding of menopause and healthy aging. Its multidisciplinary membership of 2,000 leaders in the field—including clinical and basic science experts from medicine, nursing, sociology, psychology, nutrition, anthropology, epidemiology, pharmacy, and education—makes NAMS uniquely qualified to serve as the definitive resource for health professionals and the public for accurate, unbiased information about menopause and healthy aging.

Eileen Petridis | EurekAlert!
Further information:

More articles from Health and Medicine:

nachricht NIH scientists describe potential antibody treatment for multidrug-resistant K. pneumoniae
14.03.2018 | NIH/National Institute of Allergy and Infectious Diseases

nachricht Researchers identify key step in viral replication
13.03.2018 | University of Pittsburgh Schools of the Health Sciences

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Tiny implants for cells are functional in vivo

For the first time, an interdisciplinary team from the University of Basel has succeeded in integrating artificial organelles into the cells of live zebrafish embryos. This innovative approach using artificial organelles as cellular implants offers new potential in treating a range of diseases, as the authors report in an article published in Nature Communications.

In the cells of higher organisms, organelles such as the nucleus or mitochondria perform a range of complex functions necessary for life. In the networks of...

Im Focus: Locomotion control with photopigments

Researchers from Göttingen University discover additional function of opsins

Animal photoreceptors capture light with photopigments. Researchers from the University of Göttingen have now discovered that these photopigments fulfill an...

Im Focus: Surveying the Arctic: Tracking down carbon particles

Researchers embark on aerial campaign over Northeast Greenland

On 15 March, the AWI research aeroplane Polar 5 will depart for Greenland. Concentrating on the furthest northeast region of the island, an international team...

Im Focus: Unique Insights into the Antarctic Ice Shelf System

Data collected on ocean-ice interactions in the little-researched regions of the far south

The world’s second-largest ice shelf was the destination for a Polarstern expedition that ended in Punta Arenas, Chile on 14th March 2018. Oceanographers from...

Im Focus: ILA 2018: Laser alternative to hexavalent chromium coating

At the 2018 ILA Berlin Air Show from April 25–29, the Fraunhofer Institute for Laser Technology ILT is showcasing extreme high-speed Laser Material Deposition (EHLA): A video documents how for metal components that are highly loaded, EHLA has already proved itself as an alternative to hard chrome plating, which is now allowed only under special conditions.

When the EU restricted the use of hexavalent chromium compounds to special applications requiring authorization, the move prompted a rethink in the surface...

All Focus news of the innovation-report >>>



Industry & Economy
Event News

Virtual reality conference comes to Reutlingen

19.03.2018 | Event News

Ultrafast Wireless and Chip Design at the DATE Conference in Dresden

16.03.2018 | Event News

International Tinnitus Conference of the Tinnitus Research Initiative in Regensburg

13.03.2018 | Event News

Latest News

Thawing permafrost produces more methane than expected

20.03.2018 | Earth Sciences

Scientists invented method of catching bacteria with 'photonic hook'

20.03.2018 | Physics and Astronomy

Next Generation Cryptography

20.03.2018 | Information Technology

Science & Research
Overview of more VideoLinks >>>